TY - JOUR
T1 - The No-Go and Nonsense-Mediated RNA Decay Pathways Are Regulated by Inflammatory Cytokines in Insulin-Producing Cells and Human Islets and Determine β-Cell Insulin Biosynthesis and Survival
AU - Ghiasi, Seyed Mojtaba
AU - Krogh, Nicolai
AU - Tyrberg, Björn
AU - Mandrup-Poulsen, Thomas
N1 - © 2018 by the American Diabetes Association.
PY - 2018/10
Y1 - 2018/10
N2 - Stress-related changes in b-cell mRNA levels result from a balance between gene transcription and mRNA decay. The regulation of RNA decay pathways has not been investigated in pancreatic b-cells. We found that no-go and nonsense-mediated RNA decay pathway components (RDPCs) and exoribonuclease complexes were expressed in INS-1 cells and human islets. Pelo, Dcp2, Dis3L2, Upf2, and Smg1/5/6/7 were upregulated by inflammatory cytokines in INS-1 cells under conditions where central b-cell mRNAs were downregulated. These changes in RDPC mRNA or corresponding protein levels were largely confirmed in INS-1 cells and rat/ human islets. Cytokine-induced upregulation of Pelo, Xrn1, Dis3L2, Upf2, and Smg1/6 was reduced by inducible nitric oxide synthase inhibition, as were endoplasmic reticulum (ER) stress, inhibition of Ins1/2 mRNA, and accumulated insulin secretion. Reactive oxygen species inhibition or iron chelation did not affect RDPC expression. Pelo or Xrn1 knockdown (KD) aggravated, whereas Smg6 KD ameliorated, cytokine-induced INS-1 cell death without affecting ER stress; both increased insulin biosynthesis and medium accumulation but not glucose-stimulated insulin secretion in cytokine-exposed INS-1 cells. In conclusion, RDPCs are regulated by inflammatory stress in b-cells. RDPC KD improved insulin biosynthesis, likely by preventing Ins1/2 mRNA clearance. Pelo/Xrn1 KD aggravated, but Smg6 KD ameliorated, cytokine-mediated b-cell death, possibly through prevention of proapoptotic and antiapoptotic mRNA degradation, respectively.
AB - Stress-related changes in b-cell mRNA levels result from a balance between gene transcription and mRNA decay. The regulation of RNA decay pathways has not been investigated in pancreatic b-cells. We found that no-go and nonsense-mediated RNA decay pathway components (RDPCs) and exoribonuclease complexes were expressed in INS-1 cells and human islets. Pelo, Dcp2, Dis3L2, Upf2, and Smg1/5/6/7 were upregulated by inflammatory cytokines in INS-1 cells under conditions where central b-cell mRNAs were downregulated. These changes in RDPC mRNA or corresponding protein levels were largely confirmed in INS-1 cells and rat/ human islets. Cytokine-induced upregulation of Pelo, Xrn1, Dis3L2, Upf2, and Smg1/6 was reduced by inducible nitric oxide synthase inhibition, as were endoplasmic reticulum (ER) stress, inhibition of Ins1/2 mRNA, and accumulated insulin secretion. Reactive oxygen species inhibition or iron chelation did not affect RDPC expression. Pelo or Xrn1 knockdown (KD) aggravated, whereas Smg6 KD ameliorated, cytokine-induced INS-1 cell death without affecting ER stress; both increased insulin biosynthesis and medium accumulation but not glucose-stimulated insulin secretion in cytokine-exposed INS-1 cells. In conclusion, RDPCs are regulated by inflammatory stress in b-cells. RDPC KD improved insulin biosynthesis, likely by preventing Ins1/2 mRNA clearance. Pelo/Xrn1 KD aggravated, but Smg6 KD ameliorated, cytokine-mediated b-cell death, possibly through prevention of proapoptotic and antiapoptotic mRNA degradation, respectively.
KW - Animals
KW - Apoptosis/drug effects
KW - Blotting, Northern
KW - Blotting, Western
KW - Cell Line
KW - Cell Survival/drug effects
KW - Cytokines/metabolism
KW - Exoribonucleases/metabolism
KW - Humans
KW - Insulin/metabolism
KW - Insulin-Secreting Cells/metabolism
KW - Nuclear Proteins/metabolism
KW - Phosphatidylinositol 3-Kinases/metabolism
KW - Phosphorylation/drug effects
KW - RNA/metabolism
KW - RNA Stability/genetics
KW - Rats
KW - Reverse Transcriptase Polymerase Chain Reaction
KW - Signal Transduction/drug effects
UR - http://www.scopus.com/inward/record.url?scp=85054775149&partnerID=8YFLogxK
U2 - 10.2337/db18-0073
DO - 10.2337/db18-0073
M3 - Journal article
C2 - 30065031
SN - 0012-1797
VL - 67
SP - 2019
EP - 2037
JO - Diabetes
JF - Diabetes
IS - 10
ER -